Edition:
India

Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

1,995.00GBp
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
1,995.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
158,468
52-wk High
2,272.00
52-wk Low
1,391.00

Chart for

About

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The... (more)

Overall

Beta: 0.67
Market Cap(Mil.): £2,007.26
Shares Outstanding(Mil.): 93.40
Dividend: 15.33
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Dechra Pharmaceuticals ‍Q1 performance in line with management expectations

* DECHRA PHARMACEUTICALS - ‍ PERFORMANCE IN Q1 OF FINANCIAL YEAR WAS IN LINE WITH MANAGEMENT EXPECTATIONS, WITH CONTINUED GROWTH ACROSS ALL OF ITS MARKETS​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

20 Oct 2017

Earnings vs. Estimates